Liver cancer
Results
Phase 3
This trial looked at the combination of sorafenib with chemoembolisation to treat cancer that started in the liver (primary liver cancer).
Cancer Research UK supported this trial.
Recruitment start: 19 November 2010
Recruitment end: 7 December 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Meyer
Bayer
Biocompatibles UK Limited
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUKE/08/022.
Last reviewed: 29 April 2018
CRUK internal database number: 2415
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
